highly significantp < 0.01
Analyses of metabolic pathways between groups with CK as the control and MWP-1 as the upregulated group showed that the treatment group had two upregulated metabolic pathways and one downregulated metabolic pathway, with highly significant differences ( p < 0.01) between the two pathways, namely PWY-5083 pathway, NAD/NADH phosphorylation and dephosphorylation, and LIPASYN-PWY pathway, phosphorylation ( Figure 12B ).